These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 37221639)
1. Botulinum Toxin Type A Injection for Correction of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy. Yang J; Hu X; Li Q; Huang RL J Craniofac Surg; 2023 Jul-Aug 01; 34(5):e485-e488. PubMed ID: 37221639 [TBL] [Abstract][Full Text] [Related]
2. Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy. Li D; Sun F Biomed Res Int; 2021; 2021():9514279. PubMed ID: 33791385 [TBL] [Abstract][Full Text] [Related]
3. A review of surgical techniques to correct upper eyelid retraction associated with thyroid eye disease. Kazim M; Gold KG Curr Opin Ophthalmol; 2011 Sep; 22(5):391-3. PubMed ID: 21730842 [TBL] [Abstract][Full Text] [Related]
4. [Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A]. Nava Castañeda A; Tovilla Canales JL; Garnica Hayashi L; Velasco Y Levy A J Fr Ophtalmol; 2017 Apr; 40(4):279-284. PubMed ID: 28336282 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of Botox injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage. Costa PG; Saraiva FP; Pereira IC; Monteiro ML; Matayoshi S Eye (Lond); 2009 Apr; 23(4):767-73. PubMed ID: 18535592 [TBL] [Abstract][Full Text] [Related]
6. Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections. Lee SJ; Rim TH; Jang SY; Kim CY; Shin DY; Lee EJ; Lee SY; Yoon JS Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):261-70. PubMed ID: 22968823 [TBL] [Abstract][Full Text] [Related]
7. Botox-A improve the thyroid-associated ophthalmopathy (TAO) orbital fibroblast activation through inhibiting the TGF-β/Smad signaling. Qi X; Luo B; Deng M; Cao J; Hou S; Xie Z; Tong B; Xiong W Exp Eye Res; 2022 Apr; 217():108971. PubMed ID: 35108585 [TBL] [Abstract][Full Text] [Related]
8. [Morphometric analysis of the palpebral fissure in patients with thyroid-related disfunction before and after application of botulinum toxin]. Costa PG; Saraiva FP; Matayoshi S Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):920-5. PubMed ID: 17160217 [TBL] [Abstract][Full Text] [Related]
9. [Botulinum toxin treatment for crocodile tears, spastic entropion and for dysthyroid upper eyelid retraction]. Wabbels B; Förl M Ophthalmologe; 2007 Sep; 104(9):771-6. PubMed ID: 17823804 [TBL] [Abstract][Full Text] [Related]
10. Nylon Hang Back Sutures in the Repair of Secondary Ptosis Following Overcorrected Dysthyroid Upper Eyelid Retraction. Shah-Desai S; Azarbod P; Szamocki S; Rose GE Ophthalmic Plast Reconstr Surg; 2016; 32(1):61-4. PubMed ID: 26505232 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type a for dysthyroid upper eyelid retraction. Morgenstern KE; Evanchan J; Foster JA; Cahill KV; Burns JA; Holck DE; Perry JD; Wulc AE Ophthalmic Plast Reconstr Surg; 2004 May; 20(3):181-5. PubMed ID: 15167723 [TBL] [Abstract][Full Text] [Related]
12. Transcutaneous dysport injection for treatment of upper eyelid retraction associated with thyroid eye disease. Salour H; Bagheri B; Aletaha M; Babsharif B; Kleshadi M; Abrishami M; Bagheri A Orbit; 2010 Apr; 29(2):114-8. PubMed ID: 20394553 [TBL] [Abstract][Full Text] [Related]
13. Thyroid associated ophthalmopathy: botulinum toxin A in the treatment of upper eyelid retraction--a pilot study. Träisk F; Tallstedt L Acta Ophthalmol Scand; 2001 Dec; 79(6):585-8. PubMed ID: 11782224 [TBL] [Abstract][Full Text] [Related]
15. Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy. Choi SW; Lee JY; Lew H Korean J Ophthalmol; 2016 Feb; 30(1):1-9. PubMed ID: 26865797 [TBL] [Abstract][Full Text] [Related]
16. Lower eyelid epiblepharon associated with lower eyelid retraction. Sung MS; Lee MJ; Choung HK; Kim NJ; Khwarg SI Korean J Ophthalmol; 2010 Feb; 24(1):4-9. PubMed ID: 20157407 [TBL] [Abstract][Full Text] [Related]
17. An algorithm for Botulinum toxin A injection for upper eyelid retraction associated with thyroid eye disease: long-term results. Ozturk Karabulut G; Fazil K; Saracoglu Yilmaz B; Ozturker C; Günaydın ZK; Taskapili M; Kaynak P Orbit; 2021 Oct; 40(5):381-388. PubMed ID: 32885692 [TBL] [Abstract][Full Text] [Related]
18. Histopathologic study of extraocular muscles in thyroid-associated ophthalmopathy coexisting with ocular myasthenia gravis: a case report. Ma R; Cheng Y; Gan L; Zhou X; Qian J BMC Ophthalmol; 2020 Apr; 20(1):166. PubMed ID: 32321476 [TBL] [Abstract][Full Text] [Related]
19. Results of surgical correction of upper eyelid retraction in Graves' Orbitopathy. Pinas D; O B De Keizer R; Wubbels RJ; van den Bosch WA; Paridaens D Acta Ophthalmol; 2021 Jun; 99(4):e608-e613. PubMed ID: 32930505 [TBL] [Abstract][Full Text] [Related]
20. Outcomes of various surgical procedures on acquired lower eyelid epiblepharon in thyroid associated ophthalmopathy. Park SW; Kim N; Choung HK; Khwarg SI Korean J Ophthalmol; 2012 Oct; 26(5):319-23. PubMed ID: 23060717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]